Back to database

Bronchogen

Also known as: Ala-Glu-Asp, Lung Bioregulator

Immune SystemAvailable in Russia (Khavinson peptides)OralSubcutaneous

A short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson peptide bioregulators developed at the St. Petersburg Institute of Bioregulation.

Molecular Weight

333.3 Da

Half-Life

~2-4 hours

Sequence

Ala-Glu-Asp

Mechanism of Action

Gene expression regulation in bronchial epithelial cells, improving mucosal immunity, reducing inflammation, and normalizing bronchial secretion.

Dosing Protocol

Oral: 10-20 mg daily for 10-30 days. Subcutaneous: 1mg daily.

Open peptide calculator
Reconstitution

20mg vial + 2mL BAC water for injection.

Storage

Room temperature (capsules). Lyophilized: -20°C.

Side Effects
  • ●Generally well-tolerated
  • ●Rare mild GI discomfort
Key Research Findings
  • ●Improved respiratory function in COPD patients (Khavinson studies)
  • ●Normalized bronchial epithelial gene expression in aging models
  • ●Reduced frequency of respiratory infections in elderly subjects

Research Use Only

This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.